Skip to main content
ArcticZymes Technologies logo

ArcticZymes Technologies — Investor Relations & Filings

Ticker · AZT ISIN · NO0010014632 LEI · 5967007LIEEXZXGR7K47 BR Manufacturing
Filings indexed 968 across all filing types
Latest filing 2025-10-29 Regulatory Filings
Country NO Norway
Listing BR AZT

About ArcticZymes Technologies

https://arcticzymes.com/

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and commercialization of novel recombinant enzymes. Leveraging over 30 years of expertise, the company discovers and engineers enzymes from cold-adapted Arctic marine organisms. These enzymes are designed to solve specific challenges in molecular applications, demonstrating high efficiency in demanding conditions such as low temperatures and high salinity. The product portfolio, including Salt Active Nucleases (SAN) and Cod Uracil-DNA Glycosylase, serves global partners in molecular diagnostics, gene therapy, vaccine production, and biomanufacturing. All products are manufactured at its ISO 13485 certified facility, ensuring high quality and performance for research and commercial use.

Recent filings

Filing Released Lang Actions
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess Nuclease Range. - Attachment: Brenntag_Agreement_Press_Release.pdf
Regulatory Filings Classification · 100% confidence The document is a press release announcing a new exclusive distribution agreement between ArcticZymes Technologies ASA and Brenntag Specialties Pharma. It details the nature of the partnership, the products involved, and provides quotes from company executives. Since this is a general corporate announcement regarding business operations and partnerships that does not fit into specific financial reporting categories like earnings, dividends, or board changes, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2025-10-29 English
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess Nuclease Range.
Regulatory Filings Classification · 100% confidence The document is a press release announcing a new commercial distribution partnership between ArcticZymes Technologies ASA and Brenntag Specialties Pharma. It does not fit into specific categories like financial reports, board changes, or shareholder voting. As it is a general corporate announcement regarding business operations and strategy that does not fall into the other defined categories, it is classified as a Regulatory Filing (RNS).
2025-10-29 English
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Conference - Attachment: Pareto September 16 2025 .pdf
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Pareto Securities Healthcare Conference' featuring CEO and CFO names, company overview, market analysis, strategic pillars, and financial results (Q2). It is clearly designed for an investor audience to present the company's business model, market position, and growth strategy. This fits the definition of an Investor Presentation.
2025-09-16 English
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Conference - Attachment: Pareto September 16 2025 .pdf
Investor Presentation Classification · 100% confidence The document is a slide deck titled 'Pareto Securities Healthcare Conference' featuring CEO and CFO names, company overview, market analysis, strategic pillars, and financial results (Q2). It is clearly designed for an investor audience to present the company's business model, market position, and growth strategy. This fits the definition of an Investor Presentation.
2025-09-16 English
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Conference
Report Publication Announcement Classification · 100% confidence The document is a short announcement (614 characters) stating that the company will present at a conference and includes the presentation as an attachment. According to the 'Menu vs Meal' rule, an announcement stating that a report or presentation is attached or available is classified as a Report Publication Announcement (RPA).
2025-09-16 English
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Conference
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 5,000 characters) informing stakeholders that the company is presenting at a specific conference (Pareto Securities 16th Healthcare Conference). It does not contain the actual presentation slides or detailed financial data, but rather serves as a notification of an upcoming event. According to the 'Menu vs Meal' rule, this is a notification of an event/presentation rather than the presentation itself, fitting the criteria for a general regulatory announcement.
2025-09-16 Norwegian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.